Evidence map›Paper›PMID 29977933›Full record

ArticleJournal of immunology research2018

Expression of G

Yuechi Sun, Ying Wang, Shiju Chen, Guihua Fan, Junhui Zhang, Fan Dai, Hongyan Qian, Yuan Liu, Guixiu Shi

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. The role of Th9 CD4Journal of clinical laboratory analysis · 2022
    Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yuechi SunDepartment of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.ORCID 0000-0001-6456-0363
Ying WangThe Chenggong Hospital Affiliated to Xiamen University, Xiamen 361003, China.
Shiju ChenDepartment of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.
Guihua FanXiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen 361003, China.
Junhui ZhangXiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen 361003, China.
Fan DaiXiamen Key Laboratory of Rheumatology and Clinical Immunology, Xiamen 361003, China.
Hongyan QianDepartment of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.ORCID 0000-0003-0076-8194
Yuan LiuDepartment of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.ORCID 0000-0003-2668-0350
Guixiu ShiDepartment of Rheumatology and Clinical Immunology, The First Affiliated Hospital of Xiamen University, Xiamen 361003, China.ORCID 0000-0002-8570-5274
First Affiliated Hospital of Xiamen University · CNXiamen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary Sjögren's syndrome (pSS) is a rheumatic disease characterized by the destruction of salivary and lacrimal glands, and its pathogenesis mechanism remains unclear. G

Indexed as

AdultBiomarkersCase-Control StudiesFemaleGTP-Binding Protein alpha Subunits, Gq-G11HumansInterleukin-17Leukocytes, MononuclearMaleMiddle AgedRNA, MessengerSjogren's SyndromeTh17 CellsBiomarkersGTP-Binding Protein alpha Subunits, Gq-G11IL17A protein, humanInterleukin-17RNA, Messenger

Identifiers

PMID29977933
PMCPMC6011079
OpenAlexW2805390606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.